Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
acrocyanosis
advances in neurology
adverse drug reaction
algorithm
andexanet
anemia
angiography, cerebral
antiarrhythmic drugs
anticardiolipin antibodies
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation effect
anticoagulation, perioperative
antiphospholipid antibodies
antiphospholipid antibody syndrome
apixaban
arrhythmia, cardiac
aspirin
asymptomatic
atrial appendage closure
atrial cardiopathy
atrial fibrillation
atrial fibrillation, nonvalvular
atrial fibrillation, risk stratification
atrial fibrillation, surgical treatment
atrial fibrillation, treatment
atrial flutter
atrial septal defect
autoantibodies
autoimmune disease
bedridden
blindness
brain biopsy
breast feeding
bridge therapy
bronchoscopy
cancer associated hypercoagulation
cancer, cerebrovascular accident complicating patients with
carcinoma
cardiomyopathy
carotid angiogram
carotid artery occlusion, perioperative
CAT scan
CAT scan, abnormal
CAT scan, venography
cataract surgery
cerebral edema
cerebral embolism
cerebral embolism, cardiac origin
cerebral embolism, mechanical extraction
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral veins
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, etiology
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, complications with
cerebrovascular accident, cryptogenic
cerebrovascular accident, nonarterial territory
cerebrovascular accident, postoperative
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, young adult
CHADS2
children
ciraparantag
clopidogrel
clot retrieval
coagulopathy
colonoscopy
comorbidities
complications
congenital malformation
controversies in neurology
cortical vein thrombosis
cost
cost effectiveness
coumarin
coumarin, restarting treatment
coumarin, stopping treatment
COVID-19
craniectomy, decompressive
dabigatran
Dandy Walker malformation
deafness
deafness, congenital
deafness, unilateral
delay in diagnosis
delivery, complicated
dementia
dementia, cerebrovascular disease causing
dementia, presenile
dental extraction
dental procedure, neurologic complications with
developmental abnormality of brain
developmental retardation
drug interactions
dural sinus thrombosis
echocardiogram
echocardiogram, transesophageal
edoxaban
efficacy
electromyogram
embolic stroke of unknown source
embolism
embolism, systemic
endocarditis, marantic
endoscopic surgery
endoscopy
endovascular therapy
enoxaparin
evidence-based research
facial nerve palsy
factor Xa inhibitor
falling
false positive
false positive VDRL
fetal alcohol syndrome
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fontanel, bulging
gammaglobulin therapy, intravenous
gastrointestinal bleeding
gender
head injury
headache
headache, severe
headache, thunderclap
heart valve, prosthetic
hematoma, intracerebral
hemianopia, homonymous
hemorrhage, intracranial, newborn
hemorrhagic diathesis
hemostatic therapy
heparin
heparin, low-molecular-weight
heprain induced thrombocytopenia
heralding manifestation
hip arthroplasty
Holter monitoring
hormone replacement
hormone therapy
hydrocephalus
hypercoagulable state
hypertension
iatrogenic neurologic disorders
idarucizumab
incidental finding
inferior vena cava filter
INR value, time in range
INR values
intellectual deficit
intracerebral hemorrhage
intracerebral hemorrhage, progression of
intracerebral hemorrhage, silent
intracerebral hemorrhage, treatment of
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure, increased
labor, complicated
left atrial appendage, percutaneous closure
left ventricular dysfunction
livedo reticularis
liver function enzymes
lumbar puncture, complications of
lupus anticoagulant
lymphoma
macrocephaly
malformation, CNS, congenital
mastoiditis
menopause
mental retardation
microangiopathy, brain
microcephaly
microhemorrhage, intracerebral
micropthalmia
mimics
misdiagnosis
mitral valve lesion
mitral valve prolapse
mortality
MRI
MRI, abnormal
MRI, venography
multiple organ failure
myocardial infarction
myotonia dystrophica
neurologic complications of, surgery
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic signs
NIH stroke scale
non-vitamin K antagonist oral anticoagulants
non-vitamin K antagonist oral anticoagulants, coagulation test
obstetric complications
occipital lobe, infarction
old age, neurology of
optic atrophy
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
otitis, neurologic complications with
ovarian induction
pacemaker, cardiac-transvenous
partial thromboplastin time
partial thromboplastin time, prolonged
patent foramen ovale
patent foramen ovale, percutaneous closure
patent foramen ovale, surgical treatment of
patient information and support
peripheral blood smear
peri-procedural
plasmapheresis
platelet inhibiting drugs
platelet inhibiting drugs, combined
platelet inhibiting drugs, discontinuation
postoperative neurologic complications
postpartum
practice guidelines
pregnancy, neurologic complications in
prethrombotic state
prevention of neurologic disorders
prognosis
prothrombin complex concentrate
prothrombin time
prothrombin time, prolonged
pulmonary embolism
radiofrequency ablation
Raynaud's phenomenon
recanalization, arterial
recurrent
Red flags
renal failure
renal infarct
renal vein thrombosis
reperfusion
RESPECT trial
review article
risk factors
risk stratification
risk-benefit assessment
rivaroxaban
ROCKET - AF trial
safety
schistocytes
scoliosis
screening
seizure
seizure, focal
shunt procedure, ventricular
Sneddon's syndrome
solitaire device
steroid therapy, CNS treatment and complications with
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
subdural hematoma
subdural hematoma, neonates and infants
superior sagittal sinus thrombosis
systemic illness
systemic lupus erythematosus
teratogenesis
teratogenic drugs
thrombectomy
thrombin inhibitor
thrombocytopenia
thrombolysis, mechanical
thrombophlebitis
thrombotic microangiopathy
thrombus, mural
tissue plasminogen activator, intravenous
transient ischemic attack
transient neurologic deficit
transluminal angioplasty, coronary artery
transurethral prostatectomy
treatment of neurologic disorder
Trousseau's syndrome
ultrasonography
vaccination, neurologic complications with
vaccine
valvulopathy
vasculopathy
venogram, cerebral
venous thrombosis, non-cerebral
visual field defect
vitamin K
vitamin K antagonist
Watchman device
white matter disease
workup
ximelagatran
Showing articles 100 to 150 of 2883 << Previous Next >>

Maternal & Fetal Sequelae of Anticoagulation During Pregnancy
Am J Med 68:122-140, Hall,J.G.,et al, 1980

Cerebral Microbleeds
Stroke 52:2347-2355, Graff-Radford, J.,et al, 2021

Thigh Pain After a Stroke
BMJ 371:m3697, Long, V. & Tham, S.-L., 2020

Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection
JAMA Neurol 76:657-664, Markus, H.S.,et al, 2019

Management of Anticoagulants in Patients Undergoing Endoscopic Procedure
www.UptoDate.com, Dec, Kamath, P.S., 2018

Long-Term Antithrombotic Treatment in Intracranial Hemorrhage Survivors with Atrial Fibrillation
Neurol 89:687-696, Korompoki, E.,et al, 2017

Restarting Anticoagulant Therapy after Intracranial Hemorrhage
Stroke 48:1594-1600, Murthy, S.B.,et al, 2017

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
NEJM 376:1627-1636, Calkins, H.,et al, 2017

Optimal Timing of Anticoagulant Treatment after Intracerebral Hemorrhage in Patients with Atrial Fibrillation
Stroke 48:314-320, Pennlert, J.,et al, 2017

Stroke Outcomes with use of Antithrombotics within 24 hours after Recanalization Treatment
Neurol 87:996-1002, Jeong, H.G.,et al, 2016

Prehospital Reversal of Warfarin-Related Coagulopathy in Intracerebral Hemorrhage in a Mobile Stroke Treatment Unit
Stroke 46:e118-e120, Gomes, J.A.,et al, 2015

Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation
Stroke 46:1120-1122, Tung, J.M.,et al, 2015

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
NEJM 373:823-833, Douketis,J.D.,et al, 2015

Use of Coumarin Anticoagulants and Cerebral Microbleeds in the General Population
Stroke 45:3436-3439, Akoudad, S.,et al, 2014

Antithrombotic Medications and the Etiology of Intracerebral Hemorrhage
Neurol 82:529-535, Pezzini, A.,et al, 2014

Vitamin K Antagonists and Risk of Subdural Hematoma
Stroke 45:1672-1678, Connolly, B.J.,et al, 2014

Recurrence of ICH after Resumption of Anticoagulation with VK Antagonists
Neurol 82:1020-1026,1016, Poli, D.,et al, 2014

Internal Carotid Artery Dissection and Asymmetrical Facial Flushing
Stroke 45:e78-e80, Drexler, I.,et al, 2014

Clopidogrel Plus Aspirin Versus Warfarin in Patients with Stroke and Aortic Arch Plaques
Stroke 45:1248-1257, Amarenco, P.,et al, 2014

Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients Treated with Warfarin
Ann Neurol 74:266-274, Mazya, M.V.,et al, 2013

Pacemaker of Defibrillator Surgery without Interruption of Anticoagulation
NEJM 368:2084-2093, Birnie, D.,et al, 2013

Stroke Patients with Suspected Atrial Fibrillation Should be Started on Anticoagulation Pending the Results of Long-Term Cardiac Monitoring
Stroke 44:298-299,302, Diener, H., 2013

Stroke Patients with Suspected Atrial Fibrillation Should NOT be Started on Anticoagulation WHILE AWAITING the Results of Long-Term Cardiac Monitoring
Stroke 44:300-301,302, Katsnelson, M. & Sacco, R., 2013

Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013

Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013

Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
Stroke 43:422-431, Kitsios,G.D.,et al, 2012

Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomized controlled trial
Lancet 380:1749-1758, Lopes, R.,et al, 2012

Antithrombotic Therapy and Bleeding Risk in a Prospective Cohort Study of Patients with Cerebral Cavernous Malformations
Stroke 43:3196-3199, Schneble, H.,et al, 2012

Hemostatic Therapy Should be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2535-2536,2539, Diringer, M. & Zazulia, A.R., 2012

Hemostatic Therapy Should not be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2537-2538,2539, Stapf, C., 2012

Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012

Spinal Haemorrhage During Anticoagulant Regimen for Thromboprophylaxis: A Unique Form of Central Nervous System Haemorrhage
JNNP 83:746-752, Furlan, J.C.,et al, 2012

Intracraial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation with Warfarin or Dabigatran
Stroke 43:1511-1517, Hart, R.G.,et al, 2012

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
NEJM 367:625-635, Olesen, J.B.,et al, 2012

Antiplatelets vs Anticoagulation for Dissection
Neurol 79:686-689, Kennedy, F.,et al, 2012

Do We Have to Stop Anticoagulant and Platelet-Inhibitor Treatments During Proctological Surgery?
Colorectal Dis 14:16-20, Pigot, F.,et al, 2012

Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage
Stroke 42:3661-3662, 3665, Steiner, T., 2011

Resumption of Oral Anticoagulation After Warfarin-Associated Intracereral Hemorrhage
Stroke 42:3663-3664, 3665, Schulman, S., 2011

Warfarin-Related Intraventricular Hemorrhage
Neurol 77:1840-1846, Biffi, A.,et al, 2011

Improved Late Survival and Disability After Stroke With Therapeutic Anticoagulation for Atrial Fibrillation
Stroke 42:2503-2508, Hannon, N.,et al, 2011

Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2333-2335, Seet, R.C.S.,et al, 2011

Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Stroke 42:1717-1721, Jowett, S.,et al, 2011

Subtherapeutic Warfarin Is Not Associated With Increased Hemorrhage Rates in Ischemic Strokes Treated With Tissue Plasminogen Activator
Stroke 42:1041-1045, Vergouwen,M.D.I.,et al, 2011

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011

Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
Stroke 42:112-118, Mercaldi,C.J.,et al, 2011

Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage
Stroke 41:2860-2866, Majeed,A.,et al, 2010

Effect of Home Testing of International Normalized Ratio on Clinical Events
NEJM 363:1608-1620, Matchar,D.B.,et al, 2010

Efficacy and Safety of Dabigatran Compared With Warfarin at Different Levels of International Normalised Ratio Control for Stroke Prevention in Atrial Fibrillation: An Analysis of the RE-LY Trial
Lancet 376:975-983, Wallentin,L.,et al, 2010

Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010



Showing articles 100 to 150 of 2883 << Previous Next >>